* Eikon search string for individual stock moves: STXBZ
* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh
U.S. stocks slipped on Thursday as declines in the healthcare sector outweighed gains in financial stocks.
The Dow Jones Industrial Average was down 0.19 percent at 20,909.65, the S&P 500 was down 0.28 percent at 2,378.68 and the Nasdaq Composite was down 0.19 percent at 5,889.003.
** ORACLE CORP, $46.13, +7.15 pct
The business software maker reported better-than-expected quarterly profit and adjusted revenue as the business software maker benefited from its transition to cloud-based products.
** GOPRO INC, $8.45, +14.97 pct
The wearable device maker on Wednesday estimated its first-quarter revenue at the top end of its previous forecast, and said it would cut about 270 jobs as it tries to reduce expenses in a bid to turn a profit in 2017.
** BIOGEN INC, $276.14, -5.64 pct
Brokerages Morgan Stanley and Leerink downgraded the drugmaker’s stock and price targets.
** CANADA GOOSE HOLDINGS INC, $16.46, +28.80 pct
The maker of C$900 parkas made a strong market debut on Thursday after raising C$340 million ($256 million) in an initial public offering.
** TESLA INC, $264.17, +3.30 pct
The electric carmaker said it expected to raise about $1.15 billion from stock and senior notes offering as it accelerated the launch of its new Model 3 electric sedan.
** PTC THERAPEUTICS INC, $9.64, -11.56 pct
The drug developer said it would buy Marathon Pharmaceuticals LLC’s recently-approved Duchenne muscular dystrophy drug, Emflaza, and promised to re-examine the hefty U.S. price tag on the treatment.
** DOLLAR GENERAL CORP, $74.68, +2.57 pct
The U.S. discount retailer reported a 13.7 percent increase in quarterly sales as strong demand for home products pushed up sales at its stores.
** INOVIO PHARMACEUTICALS INC, $6.14, -10.63 pct
Brokerage Piper Jaffray downgraded the vaccine developer’s stock to “neutral” from “overweight”.
** EDITAS MEDICINE INC, $25.88, +5.03 pct
The gene-editing company will sell 4 million shares in a public offering to fund preclinical studies and clinical trials for its drug programs that treat inherited eye disorders.
** GALENA BIOPHARMA INC, $0.66, +13.27 pct
The drug developer is evaluating strategic alternatives, including a sale.
** GUESS INC, $10.90, -10.87 pct
The apparel retailer posted lower-than-expected fourth-quarter profit and revenue due to weakness in Americas retail segment.
** INTREPID POTASH INC, $1.31, -8.10 pct
The potash producer offered 43.5 million shares for gross raise of nearly $52.3 million to partially repay outstanding senior note debt and for general corporate purposes.
** CATO CORP, $21.38, -6.96 pct
The women’s apparel and accessories retailer reported a 12 percent drop in sales.
** KCG HOLDINGS INC, $18.05, +6.80 pct
** VIRTU FIANCIAL INC, $16.10, -3.88 pct
Virtu has made a bid to buy rival trading firm KCG Holdings to bolster its businesses that have softened under reduced market volatility.
** B&G FOODS INC, $39.05, -7.13 pct
The snack food company said its Chief Financial Officer Thomas Crimmins resigned.
** PATHEON NV, $26.43, -15.80 pct
The drug developer reported quarterly results that missed analysts’ expectations and gave a disappointing outlook for 2017.
** HERITAGE INSURANCE HOLDINGS INC, $12.73, -9.97 pct
The property and casualty insurer posted narrower-than-expected fourth-quarter loss, but revenue fell short of estimates. (Compiled by Akankshita Mukhopadhyay in Bengaluru)